can semaglutide give you headaches Wegovy Headaches: Causes, Prevention & Management Ever started Wegovy and wondered,

Extending its weight loss portfolio The successful phase 3 trial for Lilly's orforglipron brings the drug one step closer to being approved by the U.S

This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.

David LaMond, Medical Director, Blue Sky MD GLP-1 receptor agonistslike semaglutide and tirzepatidehave transformed how we treat obesity and metabolic disease

Scientists at the University of Pennsylvania examined medical records from people taking GLP-1s for their type 2 diabetes

Semaglutide and Tirzepatide are GLP-1 receptor agonists available in NYC that aid in weight loss by enhancing feelings of fullness, reducing appetite, and improving metabolic function

Patient Portal: Log in weekly to track progress, access nutrition guidelines, and connect with our care team for support or questions